FI922105A - Foerfarande foer isolering av faktor viii. - Google Patents

Foerfarande foer isolering av faktor viii. Download PDF

Info

Publication number
FI922105A
FI922105A FI922105A FI922105A FI922105A FI 922105 A FI922105 A FI 922105A FI 922105 A FI922105 A FI 922105A FI 922105 A FI922105 A FI 922105A FI 922105 A FI922105 A FI 922105A
Authority
FI
Finland
Prior art keywords
factor viii
foerfarande foer
isolering
foer isolering
proteins
Prior art date
Application number
FI922105A
Other languages
English (en)
Other versions
FI103510B (fi
FI103510B1 (fi
FI922105A0 (fi
Inventor
Per Kaersgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI922105A0 publication Critical patent/FI922105A0/fi
Publication of FI922105A publication Critical patent/FI922105A/fi
Application granted granted Critical
Publication of FI103510B publication Critical patent/FI103510B/fi
Publication of FI103510B1 publication Critical patent/FI103510B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Amplifiers (AREA)
  • Networks Using Active Elements (AREA)
  • Housing For Livestock And Birds (AREA)
  • Cephalosporin Compounds (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI922105A 1989-11-09 1992-05-08 Menetelmä tekijän VIII eristämiseksi FI103510B1 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK562189 1989-11-09
DK562189A DK162233C (da) 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
PCT/DK1990/000279 WO1991007438A1 (en) 1989-11-09 1990-11-05 A method for isolating factor viii
DK9000279 1990-11-05

Publications (4)

Publication Number Publication Date
FI922105A0 FI922105A0 (fi) 1992-05-08
FI922105A true FI922105A (fi) 1992-05-08
FI103510B FI103510B (fi) 1999-07-15
FI103510B1 FI103510B1 (fi) 1999-07-15

Family

ID=8144000

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922105A FI103510B1 (fi) 1989-11-09 1992-05-08 Menetelmä tekijän VIII eristämiseksi

Country Status (26)

Country Link
US (1) US5245014A (fi)
EP (1) EP0524172B1 (fi)
JP (1) JP2509407B2 (fi)
CN (1) CN1044121C (fi)
AT (1) ATE118508T1 (fi)
AU (1) AU631471B2 (fi)
BG (1) BG61231B1 (fi)
CA (1) CA2073012C (fi)
CZ (1) CZ537190A3 (fi)
DE (1) DE69017050T2 (fi)
DK (1) DK162233C (fi)
ES (1) ES2068404T3 (fi)
FI (1) FI103510B1 (fi)
HU (1) HU214905B (fi)
IE (1) IE66836B1 (fi)
IL (1) IL96277A (fi)
NO (1) NO180741C (fi)
NZ (1) NZ236004A (fi)
PL (1) PL164894B1 (fi)
PT (1) PT95830B (fi)
RU (1) RU2055593C1 (fi)
SK (1) SK537190A3 (fi)
UA (1) UA29421C2 (fi)
WO (1) WO1991007438A1 (fi)
YU (1) YU47524B (fi)
ZA (1) ZA908599B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042138T3 (es) * 1989-05-24 1993-12-01 Miles Inc. Filtracion en gel del factor viii tratado termicamente.
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US6180371B1 (en) 1996-06-26 2001-01-30 Emory University Modified factor VIII
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US7560107B2 (en) 1996-06-26 2009-07-14 Emory University Modified factor VIII
US6458563B1 (en) 1996-06-26 2002-10-01 Emory University Modified factor VIII
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
US6290527B1 (en) * 1998-07-03 2001-09-18 Nippon Telegraph And Telephone Corp. Nippon telegraph and telephone corporation
US6586573B1 (en) 1999-02-22 2003-07-01 Baxter International Inc. Albumin-free Factor VIII formulations
JP2002348300A (ja) * 1999-04-12 2002-12-04 Fujimori Kogyo Co Ltd 血液凝固第ｖｉｉｉ因子および血液凝固第ｖｉｉｉ因子／フォン・ビルブラント因子複合体の精製方法
AUPR638801A0 (en) * 2001-07-13 2001-08-09 Life Therapeutics Limited Factor viii separation
ES2449044T3 (es) 2004-05-03 2014-03-18 Emory University Procedimiento de administración de fVIII sin dominio B porcino
CN101010333B (zh) * 2004-08-27 2013-08-14 诺和诺德医疗保健公司 从生物材料中纯化凝血因子xⅲ多肽
US20060226086A1 (en) * 2005-04-08 2006-10-12 Robinson Thomas C Centrifuge for blood processing systems
AU2009313325B2 (en) * 2008-11-07 2014-05-01 Takeda Pharmaceutical Company Limited Factor VIII formulations
BR112012024550B1 (pt) * 2010-03-30 2020-12-08 Octapharma Ag processo de produção de uma proteína dependente de vitamina k livre de príons em uma sequência de purificação que emprega cromatografia
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
KR101948337B1 (ko) 2010-11-05 2019-02-14 박스알타 인코퍼레이티드 증가된 특이 활성도를 갖는 항혈우병 인자 ｖｉｉｉ의 신규 변이체
CA2821711C (en) 2010-12-15 2017-10-10 Baxter International Inc. Eluate collection using conductivity gradient
CN103506080A (zh) * 2012-06-19 2014-01-15 汪志友 一种用于分离纯化凝血因子viii的介质及其制备方法
CA2886326C (en) * 2012-09-28 2021-11-02 Chugai Seiyaku Kabushiki Kaisha Method for evaluating blood coagulation reaction
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4675385A (en) * 1985-03-27 1987-06-23 Alpha Therapeutic Corporation Isolation of human plasma procoagulant protein factor VIII from biological factors
US4758657A (en) * 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
ATE112287T1 (de) * 1987-12-21 1994-10-15 Miles Inc Faktor viii- gelfiltration.
WO1989009784A1 (en) * 1988-04-08 1989-10-19 Commonwealth Serum Laboratories Commission Production of heat-stable factor viii concentrate
ES2042138T3 (es) * 1989-05-24 1993-12-01 Miles Inc. Filtracion en gel del factor viii tratado termicamente.

Also Published As

Publication number Publication date
HUT60511A (en) 1992-09-28
ZA908599B (en) 1991-07-31
DK162233B (da) 1991-09-30
WO1991007438A1 (en) 1991-05-30
FI103510B (fi) 1999-07-15
FI103510B1 (fi) 1999-07-15
IE904022A1 (en) 1991-05-22
IL96277A0 (en) 1991-08-16
DK562189A (da) 1991-05-10
DE69017050T2 (de) 1995-06-14
ES2068404T3 (es) 1995-04-16
NO180741C (no) 1997-06-11
EP0524172B1 (en) 1995-02-15
PT95830B (pt) 1997-11-28
CA2073012A1 (en) 1991-05-10
HU9201551D0 (en) 1992-08-28
NO180741B (no) 1997-03-03
YU47524B (sh) 1995-10-03
DK162233C (da) 1992-03-16
HU214905B (hu) 1998-07-28
CN1044121C (zh) 1999-07-14
CN1051732A (zh) 1991-05-29
DE69017050D1 (de) 1995-03-23
NO921839L (no) 1992-07-08
JP2509407B2 (ja) 1996-06-19
DK562189D0 (da) 1989-11-09
NO921839D0 (no) 1992-05-08
BG96316A (bg) 1993-12-24
SK278640B6 (en) 1997-12-10
PL287703A1 (en) 1991-12-02
FI922105A0 (fi) 1992-05-08
SK537190A3 (en) 1997-12-10
US5245014A (en) 1993-09-14
BG61231B1 (en) 1997-03-31
AU6747090A (en) 1991-06-13
IE66836B1 (en) 1996-02-07
CZ537190A3 (cs) 1998-05-13
PL164894B1 (pl) 1994-10-31
JPH05501557A (ja) 1993-03-25
UA29421C2 (uk) 2000-11-15
YU210590A (sh) 1993-05-28
RU2055593C1 (ru) 1996-03-10
PT95830A (pt) 1991-09-30
CA2073012C (en) 1996-03-19
EP0524172A1 (en) 1993-01-27
AU631471B2 (en) 1992-11-26
NZ236004A (en) 1991-11-26
IL96277A (en) 1995-07-31
ATE118508T1 (de) 1995-03-15

Similar Documents

Publication Publication Date Title
NO180741C (no) Fremgangsmåte for isolering av Faktor VIII
YU191387A (en) Process for extracting lipofilic proteins from host cells of pichia origin
AU5378686A (en) Process for the extraction and purification of proteins from culture media producing them
AU584576B2 (en) Process for separation of hydrocarbon gases
NZ218913A (en) Process for separating components of natural gas
ATE72121T1 (de) Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen.
AU584577B2 (en) Process for separation of hydrocarbon gases
GB2218991B (en) Enzymatic membrane method for the synthesis of peptides and the separation of optical isomers
AU584578B2 (en) Process for separation of hydrocarbon mixtures
AU582497B2 (en) Improved process for separation of acid gases
PT84879A (en) Process for the production of hybrid polypetides from bacterial clones comprising somatocrinine and alpha 1-antitrypsin and process for the production of somatocrinine
EP0213814A3 (en) Synthesis of tricyclazole
GB1479512A (en) Dimeric indole alkaloid purification process
DK690587A (da) Tetrapeptid, dets fremstilling og anvendelse
KR920701461A (ko) 펩티드의 합성 및 분리를 위한 효소막법
AU1929188A (en) Process for recovery of gold
BG44094A1 (en) Method for separating of furfurol from hydrolysate
HK50691A (en) Enzymatic membrane method for the synthesis of peptides and the separation of optical isomers
CS60486A1 (en) Separation method of smoke matters for smoke preparates production